JENBURKT PHARMACEUTICALS LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹675
- Today's High:
- ₹710.3
- Open Price:
- ₹710.3
- 52W Low:
- ₹503.6944
- 52W High:
- ₹785.0292
- Prev. Close:
- ₹701.4
- Volume:
- 2761
Company Statistics
- Market Cap.:
- ₹3.41 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹851.36 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
JENBURKT PHARMACEUTICALS LTD. had its IPO on under the ticker symbol JENBURPH.
The company operates in the sector and industry. JENBURKT PHARMACEUTICALS LTD. has a staff strength of 0 employees.
Stock update
Shares of JENBURKT PHARMACEUTICALS LTD. opened at ₹710.3 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹675 - ₹710.3, and closed at ₹684.45.
This is a -2.42% slip from the previous day's closing price.
A total volume of 2,761 shares were traded at the close of the day’s session.
In the last one week, shares of JENBURKT PHARMACEUTICALS LTD. have slipped by -2.57%.
JENBURKT PHARMACEUTICALS LTD.'s Key Ratios
JENBURKT PHARMACEUTICALS LTD. has a market cap of ₹3.41 billion, indicating a price to book ratio of 2.4105 and a price to sales ratio of 2.3489.
In the last 12-months JENBURKT PHARMACEUTICALS LTD.’s revenue was ₹0 with a gross profit of ₹851.36 million and an EBITDA of ₹0. The EBITDA ratio measures JENBURKT PHARMACEUTICALS LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, JENBURKT PHARMACEUTICALS LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q1, JENBURKT PHARMACEUTICALS LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
JENBURKT PHARMACEUTICALS LTD.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 21.3781
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into JENBURKT PHARMACEUTICALS LTD.’s profitability.
JENBURKT PHARMACEUTICALS LTD. stock is trading at a EV to sales ratio of 1.9833 and a EV to EBITDA ratio of 7.8378. Its price to sales ratio in the trailing 12-months stood at 2.3489.
JENBURKT PHARMACEUTICALS LTD. stock pays annual dividends of ₹10.2 per share, indicating a yield of 1.39% and a payout ratio of 26.83%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.42 billion
- Total Liabilities
- ₹157.62 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 26.83%
JENBURKT PHARMACEUTICALS LTD. ended 2024 with ₹1.42 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.42 billion while shareholder equity stood at ₹1.22 billion.
JENBURKT PHARMACEUTICALS LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹157.62 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0.00 in goodwill. Its cash balance stood at ₹36.60 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
JENBURKT PHARMACEUTICALS LTD.’s total current assets stands at ₹810.91 million while long-term investments were ₹0 and short-term investments were ₹509.23 million. Its net receivables were ₹169.62 million compared to accounts payable of ₹60.97 million and inventory worth ₹83.38 million.
In 2024, JENBURKT PHARMACEUTICALS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, JENBURKT PHARMACEUTICALS LTD. paid ₹0.27 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹684.45
- 52-Week High
- ₹785.0292
- 52-Week Low
- ₹503.6944
- Analyst Target Price
- ₹
JENBURKT PHARMACEUTICALS LTD. stock is currently trading at ₹684.45 per share. It touched a 52-week high of ₹785.0292 and a 52-week low of ₹785.0292. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹726.44 and 200-day moving average was ₹677.04 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.